Company profile: Within3
1.1 - Company Overview
Company description
- Provider of a SaaS virtual engagement and digital collaboration platform for life science companies to compliantly connect and engage physicians, nurses, payers, and patients in groups large or small; offerings include an Insights Management Platform, AI-powered virtual engagement applications for global stakeholder discussions, client success support, and data science services for disease community analysis.
Products and services
- Virtual Engagement Applications: AI-enabled online tools that connect physicians, nurses, payers, and patients globally, manage conversational insights, and perform real-time discussion analysis within regulatory-compliant groups large or small
- Insights Management Platform: SaaS-based platform for life science companies to gather, integrate, and analyze stakeholder insights, architected to inform decision-making by unifying inputs across engagements
- Data Science Services: Custom analysis by data scientists that constructs a precise view of disease communities for life science organizations, focusing insights from collaborations among physicians, nurses, payers, and patients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Within3
NTx
HQ: United States
Website
- Description: Provider of a proprietary host-independent biological manufacturing and development platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NTx company profile →
ESAC
HQ: United States
Website
- Description: Provider of research data management, bioinformatics, and healthcare information technology solutions for government, commercial, and academic clients, addressing health IT interoperability and standards, genomics and proteomics technologies, data coordination, and big data integration and visualization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ESAC company profile →
Octant
HQ: United States
Website
- Description: Provider of a cellular intelligence platform for studying protein misfolding in human cells and enabling high-throughput screening; multiplexed readouts to measure protein folding and trafficking across hundreds of mutations and conditions; and development of novel therapeutics guided by massive datasets in engineered human cells to improve health and treat disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Octant company profile →
NEC OncoImmunity
HQ: Norway
Website
- Description: Provider of AI-driven biotech solutions offering proprietary machine-learning software to predict bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. Products include NEC Immune Profiler, AI-driven neoantigen prediction for personalized cancer vaccines and cell therapies, and AI-based vaccine design for broadly protective vaccines against diverse viral species.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NEC OncoImmunity company profile →
Cryoport
HQ: United States
Website
- Description: Provider of outsourced temperature-controlled shipping and logistics for biological materials, offering ISO 21973-compliant shipping systems across cryogenic, ultra-cold (dry ice), refrigerated and controlled room temperatures; IntegriCell cryopreservation; integrated BioServices and biostorage; consulting to de-risk biologics and cell & gene therapy supply chains; and comprehensive upstream/downstream supply chain management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoport company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Within3
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Within3
2.2 - Growth funds investing in similar companies to Within3
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Within3
4.2 - Public trading comparable groups for Within3
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →